辛伐他汀治疗高血压合并冠心病临床应用探讨

Simvastatin in the treatment of hypertension and coronary heart disease clinical observation

目的探讨辛伐他汀在高血压合并冠心病患者中的临床效果。方法对2013年4月—2014年4月来该院诊断、治疗的80例患者相关资料进行分析,根据不同治疗方法分为两组。对照组采用血脂康胶囊治疗,实验组采用辛伐他汀片治疗,比较两组治疗效果。结果验组TC指标为(4.07±0.19)%、TG指标为(1.92±0.45)%、LDL-C指标为(2.13±0.18)mmo L/L,均低于对照组,差异有统计学意义(P<0.05);实验组HDL-C指标为(1.27±0.22)mmo L/L,高于对照组,差异有统计学意义(P<0.05);实验组95%治疗效果理想,高于对照组(85%),差异有统计学意义(P<0.05)。结论血压患者合并冠心病发病率较高,采用辛伐他汀片治疗效果理想,值得推广使用。

Objective To investigate the clinical effect of simvastatin combined withcoronary heart disease in patients with hyper-tension. Methods 80 cases of patient data in our hospital were analyzed, according to the different treatment methods are divided into two groups. Control group withXuezhikang Capsule in the treatment of experimental group, using Simvastatin Tablets treat-ment, the therapeutic effect was compared between the two groups. Results the experimental group TC index （4.07±0.19）%, TG in-dex （1.92±0.45）%, LDL-C index （2.13±0.18） mmoL/L, were lower than the control group（P〈0.05）;the HDL-C index as the experi-mental group （1.27±0.22） mmoL/L,higher than that of the control group （P〈0.05）; the ideal treatment effect the experimental group was 95%, higher than that of the control group （85%）（P〈0.05）. Conclusion The high incidence of hypertension patients complicat-ed with coronary heart disease rate, using Simvastatin Tablets therapeutic effect, is worthy to be popularized.